Crohns Disease Therapeutics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Crohn's Disease Therapeutics Market to 2027 - Global Analysis and Forecasts By Drug Class (Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory drugs (NSAIDs), Corticosteroids, TNF Inhibitors, Aminosalicyclates, Immunomodulators); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography

Report Code: TIPRE00004296 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Crohn's disease is an inflammatory bowel disease (IBD). It causes inflammation of the digestive tract, which leads to abdominal pain, cramping, diarrhea, blood in the stool, weight loss, fatigue and malnutrition. Inflammation caused by Crohn's disease can involve different areas of the digestive tract in different people. It is caused due to virus or bacterium which triggers Crohn's disease. Crohn's disease can be treated with medications and surgery. Medicines prescribed to treat Crohn's disease are: metronidazole, ciprofloxacin, other antibiotics, aminosalicylates, corticosteroids, immunomodulators and biologics.

MARKET DYNAMICS
The Crohn's disease therapeutics market is expected to grow during the forecast period due to rising development of novel biological agents and anti-cytokine agents, constant efforts in the development of biosimilars, and growing global incidence of gastrointestinal diseases. However, low awareness about the available treatment options among the people of middle and low-income economies as well as biologics going off-patent are expected to hampers the market growth.

MARKET SCOPE
The "Global Crohn's Disease Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of enteral feeding formulas market with detailed market segmentation by drug class, distribution channel and geography. The global Crohn's disease therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading enteral feeding formulas market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Crohn's disease therapeutics market is segmented on the basis of drug class and distribution channel. Based on drug class, the market is classified as anti-inflammatory biologics, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, TNF inhibitors, aminosalicyclates, immunomodulators. Based on distribution channel, the Crohn's disease therapeutics market is segmented into hospital pharmacy, retail pharmacy, online pharmacy.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Crohn's disease therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Crohn's disease therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Crohn's Disease Therapeutics Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Crohn's Disease Therapeutics Market in these regions. 


MARKET PLAYERS

The reports cover key developments in the Crohn's disease therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Crohn's disease therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for Crohn's disease therapeutics market in the global market. Below mentioned is the list of few companies engaged in the Crohn's disease therapeutics market.

The report also includes the profiles of key Crohn's disease therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  • ABBVIE, INC.
  • JOHNSON AND JOHNSON PRIVATE LIMITED
  • GLAXOSMITHKLINE PLC
  • MERCK AND CO., INC.
  • NOVARTIS AG
  • CELGENE CORPORATION
  • GENENTECH
  • PFIZER INC.
  • NESTLe HEALTH SCIENCE
  • BOEHRINGER INGELHEIM GMBH

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Crohn's Disease Therapeutics Market - By Drug Class
 1.3.2 Crohn's Disease Therapeutics Market - By Distribution Channel
 1.3.3 Crohn's Disease Therapeutics Market - By Region
 1.3.3.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. CROHN'S DISEASE THERAPEUTICS MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS

5. CROHN'S DISEASE THERAPEUTICS MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. CROHN'S DISEASE THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
 6.1. CROHN'S DISEASE THERAPEUTICS - GLOBAL MARKET OVERVIEW
 6.2. CROHN'S DISEASE THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
 6.3. MARKET POSITIONING/MARKET SHARE

7. CROHN'S DISEASE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
 7.1. OVERVIEW
 7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
 7.3. ANTI-INFLAMMATORY BIOLOGICS
 7.3.1. Overview
 7.3.2. Anti-inflammatory Biologics Market Forecast and Analysis
 7.4. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)
 7.4.1. Overview
 7.4.2. Non-Steroidal Anti-inflammatory drugs (NSAIDs) Market Forecast and Analysis
 7.5. CORTICOSTEROIDS
 7.5.1. Overview
 7.5.2. Corticosteroids Market Forecast and Analysis
 7.6. TNF INHIBITORS
 7.6.1. Overview
 7.6.2. TNF Inhibitors Market Forecast and Analysis
 7.7. AMINOSALICYCLATES
 7.7.1. Overview
 7.7.2. Aminosalicyclates Market Forecast and Analysis
 7.8. IMMUNOMODULATORS
 7.8.1. Overview
 7.8.2. Immunomodulators Market Forecast and Analysis

8. CROHN'S DISEASE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
 8.1. OVERVIEW
 8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
 8.3. HOSPITAL PHARMACY
 8.3.1. Overview
 8.3.2. Hospital Pharmacy Market Forecast and Analysis
 8.4. RETAIL PHARMACY
 8.4.1. Overview
 8.4.2. Retail Pharmacy Market Forecast and Analysis
 9.5. ONLINE PHARMACY
 8.5.1. Overview
 8.5.2. Online Pharmacy Market Forecast and Analysis

9. CROHN'S DISEASE THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
 9.1. NORTH AMERICA
 9.1.1 North America Crohn's Disease Therapeutics Market Overview
 9.1.2 North America Crohn's Disease Therapeutics Market Forecasts and Analysis
 9.1.3 North America Crohn's Disease Therapeutics Market Forecasts and Analysis - By Drug Class
 9.1.4 North America Crohn's Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
 9.1.5 North America Crohn's Disease Therapeutics Market Forecasts and Analysis - By Countries
 9.1.5.1 United States Crohn's Disease Therapeutics Market
 9.1.5.1.1 United States Crohn's Disease Therapeutics Market by Drug Class
 9.1.5.1.2 United States Crohn's Disease Therapeutics Market by Distribution Channel
 9.1.5.2 Canada Crohn's Disease Therapeutics Market
 9.1.5.2.1 Canada Crohn's Disease Therapeutics Market by Drug Class
 9.1.5.2.2 Canada Crohn's Disease Therapeutics Market by Distribution Channel
 9.1.5.3 Mexico Crohn's Disease Therapeutics Market
 9.1.5.3.1 Mexico Crohn's Disease Therapeutics Market by Drug Class
 9.1.5.3.2 Mexico Crohn's Disease Therapeutics Market by Distribution Channel
 9.2. EUROPE
 9.2.1 Europe Crohn's Disease Therapeutics Market Overview
 9.2.2 Europe Crohn's Disease Therapeutics Market Forecasts and Analysis
 9.2.3 Europe Crohn's Disease Therapeutics Market Forecasts and Analysis - By Drug Class
 9.2.4 Europe Crohn's Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
 9.2.5 Europe Crohn's Disease Therapeutics Market Forecasts and Analysis - By Countries
 9.2.5.1 Germany Crohn's Disease Therapeutics Market
 9.2.5.1.1 Germany Crohn's Disease Therapeutics Market by Drug Class
 9.2.5.1.2 Germany Crohn's Disease Therapeutics Market by Distribution Channel
 9.2.5.2 France Crohn's Disease Therapeutics Market
 9.2.5.2.1 France Crohn's Disease Therapeutics Market by Drug Class
 9.2.5.2.2 France Crohn's Disease Therapeutics Market by Distribution Channel
 9.2.5.3 Italy Crohn's Disease Therapeutics Market
 9.2.5.3.1 Italy Crohn's Disease Therapeutics Market by Drug Class
 9.2.5.3.2 Italy Crohn's Disease Therapeutics Market by Distribution Channel
 9.2.5.4 Spain Crohn's Disease Therapeutics Market
 9.2.5.4.1 Spain Crohn's Disease Therapeutics Market by Drug Class
 9.2.5.4.2 Spain Crohn's Disease Therapeutics Market by Distribution Channel
 9.2.5.5 United Kingdom Crohn's Disease Therapeutics Market
 9.2.5.5.1 United Kingdom Crohn's Disease Therapeutics Market by Drug Class
 9.2.5.5.2 United Kingdom Crohn's Disease Therapeutics Market by Distribution Channel
 9.3. ASIA-PACIFIC
 9.3.1 Asia-Pacific Crohn's Disease Therapeutics Market Overview
 9.3.2 Asia-Pacific Crohn's Disease Therapeutics Market Forecasts and Analysis
 9.3.3 Asia-Pacific Crohn's Disease Therapeutics Market Forecasts and Analysis - By Drug Class
 9.3.4 Asia-Pacific Crohn's Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
 9.3.5 Asia-Pacific Crohn's Disease Therapeutics Market Forecasts and Analysis - By Countries
 9.3.5.1 Australia Crohn's Disease Therapeutics Market
 9.3.5.1.1 Australia Crohn's Disease Therapeutics Market by Drug Class
 9.3.5.1.3 Australia Crohn's Disease Therapeutics Market by Distribution Channel
 9.3.5.2 China Crohn's Disease Therapeutics Market
 9.3.5.2.1 China Crohn's Disease Therapeutics Market by Drug Class
 9.3.5.2.2 China Crohn's Disease Therapeutics Market by Distribution Channel
 9.3.5.3 India Crohn's Disease Therapeutics Market
 9.3.5.3.1 India Crohn's Disease Therapeutics Market by Drug Class

 10.3.5.3.2 India Crohn's Disease Therapeutics Market by Distribution Channel
 10.3.5.4 Japan Crohn's Disease Therapeutics Market
 10.3.5.4.1 Japan Crohn's Disease Therapeutics Market by Drug Class
 10.3.5.4.2 Japan Crohn's Disease Therapeutics Market by Distribution Channel
 10.3.5.5 South Korea Crohn's Disease Therapeutics Market
 10.3.5.5.1 South Korea Crohn's Disease Therapeutics Market by Drug Class
 10.3.5.5.2 South Korea Crohn's Disease Therapeutics Market by Distribution Channel
 10.4. MIDDLE EAST AND AFRICA
 10.4.1 Middle East and Africa Crohn's Disease Therapeutics Market Overview
 10.4.2 Middle East and Africa Crohn's Disease Therapeutics Market Forecasts and Analysis
 10.4.3 Middle East and Africa Crohn's Disease Therapeutics Market Forecasts and Analysis - By Drug Class
 10.4.4 Middle East and Africa Crohn's Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
 10.4.5 Middle East and Africa Crohn's Disease Therapeutics Market Forecasts and Analysis - By Countries
 10.4.5.1 South Africa Crohn's Disease Therapeutics Market
 10.4.5.1.1 South Africa Crohn's Disease Therapeutics Market by Drug Class
 10.4.5.1.2 South Africa Crohn's Disease Therapeutics Market by Distribution Channel
 10.4.5.2 Saudi Arabia Crohn's Disease Therapeutics Market
 10.4.5.2.1 Saudi Arabia Crohn's Disease Therapeutics Market by Drug Class
 10.4.5.2.2 Saudi Arabia Crohn's Disease Therapeutics Market by Distribution Channel
 10.4.5.3 U.A.E Crohn's Disease Therapeutics Market
 10.4.5.3.1 U.A.E Crohn's Disease Therapeutics Market by Drug Class
 10.4.5.3.2 U.A.E Crohn's Disease Therapeutics Market by Distribution Channel
 10.5. SOUTH AND CENTRAL AMERICA
 10.5.1 South and Central America Crohn's Disease Therapeutics Market Overview
 10.5.2 South and Central America Crohn's Disease Therapeutics Market Forecasts and Analysis
 10.5.3 South and Central America Crohn's Disease Therapeutics Market Forecasts and Analysis - By Drug Class
 10.5.4 South and Central America Crohn's Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
 10.5.5 South and Central America Crohn's Disease Therapeutics Market Forecasts and Analysis - By Countries
 10.5.5.1 Brazil Crohn's Disease Therapeutics Market
 10.5.5.1.1 Brazil Crohn's Disease Therapeutics Market by Drug Class
 10.5.5.1.2 Brazil Crohn's Disease Therapeutics Market by Distribution Channel
 10.5.5.2 Argentina Crohn's Disease Therapeutics Market
 10.5.5.2.1 Argentina Crohn's Disease Therapeutics Market by Drug Class
 10.5.5.2.2 Argentina Crohn's Disease Therapeutics Market by Distribution Channel

11. INDUSTRY LANDSCAPE
 11.1. MERGERS AND ACQUISITIONS
 11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 11.3. NEW PRODUCT LAUNCHES
 11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. CROHN'S DISEASE THERAPEUTICS MARKET, KEY COMPANY PROFILES
 12.1. ABBVIE, INC.
 12.1.1. Key Facts
 12.1.2. Business Description
 12.1.3. Products and Services
 12.1.4. Financial Overview
 12.1.5. SWOT Analysis
 12.1.6. Key Developments
 12.2. JOHNSON AND JOHNSON PRIVATE LIMITED
 12.2.1. Key Facts
 12.2.2. Business Description
 12.2.3. Products and Services
 12.2.4. Financial Overview
 12.2.5. SWOT Analysis
 12.2.6. Key Developments
 12.3. GLAXOSMITHKLINE PLC
 12.3.1. Key Facts
 12.3.2. Business Description
 12.3.3. Products and Services
 12.3.4. Financial Overview
 12.3.5. SWOT Analysis
 12.3.6. Key Developments
 12.4. MERCK AND CO., INC.
 12.4.1. Key Facts
 12.4.2. Business Description
 12.4.3. Products and Services
 12.4.4. Financial Overview
 12.4.5. SWOT Analysis
 12.4.6. Key Developments
 12.5. NOVARTIS AG.
 12.5.1. Key Facts
 12.5.2. Business Description
 12.5.3. Products and Services
 12.5.4. Financial Overview
 12.5.5. SWOT Analysis
 12.5.6. Key Developments
 12.6. CELGENE CORPORATION
 12.6.1. Key Facts
 12.6.2. Business Description
 12.6.3. Products and Services
 12.6.4. Financial Overview
 12.6.5. SWOT Analysis
 12.6.6. Key Developments
 12.7. GENENTECH
 12.7.1. Key Facts
 12.7.2. Business Description
 12.7.3. Products and Services
 12.7.4. Financial Overview
 12.7.5. SWOT Analysis
 12.7.6. Key Developments
 12.8. PFIZER INC.
 12.8.1. Key Facts
 12.8.2. Business Description
 12.8.3. Products and Services
 12.8.4. Financial Overview
 12.8.5. SWOT Analysis
 12.8.6. Key Developments
 12.9. NESTLé HEALTH SCIENCE
 12.9.1. Key Facts
 12.9.2. Business Description
 12.9.3. Products and Services
 12.9.4. Financial Overview
 12.9.5. SWOT Analysis
 12.9.6. Key Developments
 12.10. BOEHRINGER INGELHEIM GMBH
 12.10.1. Key Facts
 12.10.2. Business Description
 12.10.3. Products and Services
 12.10.4. Financial Overview
 12.10.5. SWOT Analysis
 12.10.6. Key Developments

13. APPENDIX
 13.1. ABOUT THE INSIGHT PARTNERS
 13.2. GLOSSARY OF TERMS

 

The List of Companies

1. ABBVIE, INC.
2. JOHNSON AND JOHNSON PRIVATE LIMITED
3. GLAXOSMITHKLINE PLC
4. MERCK AND CO., INC.
5. NOVARTIS AG
6. CELGENE CORPORATION
7. GENENTECH
8. PFIZER INC.
9. NESTLe HEALTH SCIENCE
10. BOEHRINGER INGELHEIM GMBH

 

Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book